Press Release: BioGenex Labs : BioGenex Introduces PD1 and PDL-1 Antibodies for Immunohistochemistry (IHC)
FREMONT, Calif., March 8, 2017 /PRNewswire/ -- BioGenex, a global leader in molecular pathology announced introduction of monoclonal antibodies for the detection of immune checkpoint proteins: PD1 and PD-L1 by immunohistochemistry (IHC). The antibodies are CE marked and are also available for p
Read full article »
Biogenex develops, manufactures and markets automated molecular diagnostic instruments and reagents for diagnostics and life science research.
Read more